Who
Taiyin Yang
Director
Company insider
Files Form 4 as: Director, Kodiak Sciences; Director, Kronos Bio; SVP, Pharm Dev & Mfg, Gilead Sciences.
In numbers
- Trades disclosed
- 72
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $5.8M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 25 Jan 2006
- Last trade
- 30 Jun 2026
- Last filed
- 2 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jun 2026filed 2 Jul 2026 | KOD Kodiak Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,731 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | KOD Kodiak Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,731 at $0.00 | filing |
| 30 Jun 2025filed 2 Jul 2025 | KOD Kodiak Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 20 Jun 2025filed 20 Jun 2025 | Kronos Biooption or derivative | SEC FORM 4 Code D | —41,200 at $0.00 | filing |
| 20 Jun 2025filed 20 Jun 2025 | Kronos Biooption or derivative | SEC FORM 4 Code D | —5,150 at $0.00 | filing |
| 20 Jun 2025filed 20 Jun 2025 | Kronos Biooption or derivative | SEC FORM 4 Code D | —17,000 at $0.00 | filing |
| 20 Jun 2025filed 20 Jun 2025 | Kronos Biooption or derivative | SEC FORM 4 Code D | —34,000 at $0.00 | filing |
| 20 Jun 2025filed 20 Jun 2025 | Kronos Biooption or derivative | SEC FORM 4 Code D | —34,000 at $0.00 | filing |
| 20 Jun 2025filed 20 Jun 2025 | Kronos Bio | SEC FORM 4 Code U | $6,46011,333 at $0.57 | filing |
| 28 Jun 2024filed 1 Jul 2024 | KOD Kodiak Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 25 Jun 2024filed 26 Jun 2024 | Kronos Biooption or derivative | SEC FORM 4 Code A | —34,000 at $0.00 | filing |
| 30 Jun 2023filed 3 Jul 2023 | KOD Kodiak Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 22 Jun 2023filed 26 Jun 2023 | Kronos Biooption or derivative | SEC FORM 4 Code A | —34,000 at $0.00 | filing |
| 30 Jun 2022filed 5 Jul 2022 | KOD Kodiak Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 22 Jun 2022filed 29 Jun 2022 | Kronos Biooption or derivative | SEC FORM 4 Code A | —17,000 at $0.00 | filing |
| 22 Jun 2022filed 29 Jun 2022 | Kronos Bio | SEC FORM 4 Code A | —11,333 at $0.00 | filing |
| 30 Jun 2021filed 2 Jul 2021 | KOD Kodiak Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,368 at $0.00 | filing |
| 22 Jun 2021filed 23 Jun 2021 | Kronos Biooption or derivative | SEC FORM 4 Code A | —5,150 at $0.00 | filing |
| 25 Mar 2021filed 26 Mar 2021 | Kronos Biooption or derivative | SEC FORM 4 Code A | —41,200 at $0.00 | filing |
| 30 Jun 2020filed 2 Jul 2020 | KOD Kodiak Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,417 at $0.00 | filing |
News
Gilead Sciences Is on an FDA Approval Hot Streak. Should You Buy the Stock Like There's No Tomorrow?GILD · fool.com · 18 Oct 2026Gilead Sciences Clears Its February High at $153.54GILD · 247wallst.com · 15 Oct 2026Gilead Sciences, Inc. $GILD Stock Acquired by First Citizens Bank & Trust Co.GILD · dailypolitical.com · 14 Oct 2026
0 headlines in the last 90 days name Taiyin Yang; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.